AEPCX
Price
$61.21
Change
+$0.27 (+0.44%)
Updated
Aug 20 closing price
Net Assets
137.41B
NIQVX
Price
$15.02
Change
-$0.08 (-0.53%)
Updated
Aug 20 closing price
Net Assets
1.02B
Interact to see
Advertisement

AEPCX vs NIQVX

AEPCX vs NIQVX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. NIQVX commentary
Aug 21, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and NIQVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. NIQVX (1.02B). AEPCX pays higher dividends than NIQVX: AEPCX (2.13) vs NIQVX (1.01). AEPCX was incepted earlier than NIQVX: AEPCX (25 years) vs NIQVX (14 years). AEPCX (1.58) is less costly to investors than NIQVX (1.22). NIQVX is a more actively managed with annual turnover of: 61.00 vs. AEPCX (50.00). AEPCX has a lower initial minimum investment than NIQVX: AEPCX (250) vs NIQVX (1000). AEPCX annual gain was more profitable for investors over the last year : 4.80 vs. NIQVX (1.94). AEPCX (-4.80) and NIQVX (-4.82) have equivalent 5 years return.
AEPCXNIQVXAEPCX / NIQVX
Total Expense Ratio1.581.22130%
Annual Report Gross Expense Ratio1.581.22130%
Fund Existence25 years14 years-
Gain YTD5.4876.11490%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets137B1.02B13,431%
Annual Yield % from dividends2.131.01211%
Returns for 1 year4.801.94248%
Returns for 3 years24.5733.5573%
Returns for 5 years-4.80-4.82100%
Returns for 10 years38.4850.0277%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSFBX27.600.36
+1.32%
Morgan Stanley Inst Global Franchise A
WGROX83.030.76
+0.92%
Wasatch Core Growth
PBSYX20.40-0.18
-0.87%
Polen 5Perspectives Small Growth Y
JMNSX15.17-0.20
-1.30%
JPMorgan Research Market Neutral I
PASTX67.83-1.16
-1.68%
T. Rowe Price Science & Tech Adv